Mates Sharon's Form 4 filing
Intra-Cellular Therapies, Inc. (ITCI) · filed Dec 6, 2024
- Accession no.
- 0000950170-24-134240
- Filed
- Dec 6, 2024
- Trade date
- Dec 4-5, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $8.72M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mates SharonCIK 0001585699 | Director, Officer (Chairman and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2024 | Common Stock | MOption exerciseAcquired | +51,000 | $12.73 | +$649,230 | 1,121,329 | Direct | |
| Dec 4, 2024 | Common Stock | SSaleDisposed | −27,667 | $85.62 | −$2,368,848.54 | 1,093,662 | Direct | |
| Dec 4, 2024 | Common Stock | SSaleDisposed | −23,333 | $86.00 | −$2,006,638 | 1,070,329 | Direct | |
| Dec 5, 2024 | Common Stock | MOption exerciseAcquired | +51,697 | $12.73 | +$658,102.81 | 1,122,026 | Direct | |
| Dec 5, 2024 | Common Stock | SSaleDisposed | −50,163 | $84.06 | −$4,216,701.78 | 1,071,863 | Direct | |
| Dec 5, 2024 | Common Stock | SSaleDisposed | −1,534 | $84.69 | −$129,914.46 | 1,070,329 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2024 | Common Stock | MOption exerciseDisposed | −51,000 | $0.00 | $0 | 51,697 | Direct | |
| Dec 5, 2024 | Common Stock | MOption exerciseDisposed | −51,697 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.